Moderna, Inc.
MRNA
$59.81
$0.641.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 41.77% | -62.59% | -313.00% | 75.76% | 15.04% |
| Total Depreciation and Amortization | 6.78% | -11.94% | 28.85% | -8.77% | 46.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.87% | -22.31% | 9.24% | -18.49% | 37.74% |
| Change in Net Operating Assets | -85.71% | -64.53% | 290.59% | -175.42% | -40.76% |
| Cash from Operations | 16.51% | -167.74% | 209.80% | 7.83% | 11.38% |
| Capital Expenditure | 40.32% | -58.97% | -18.18% | -1,000.00% | 97.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,714.29% | -55.56% | -101.23% | 29.28% | -33.06% |
| Cash from Investing | 532.89% | -58.33% | -106.86% | 24.11% | -22.74% |
| Total Debt Issued | -- | -- | -- | -- | -200.00% |
| Total Debt Repaid | -- | -- | -300.00% | 0.00% | -- |
| Issuance of Common Stock | 21.05% | 18.75% | 700.00% | -85.71% | 366.67% |
| Repurchase of Common Stock | 0.00% | -100.00% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.65% | -97.07% | 58,200.00% | -111.11% | 125.00% |
| Foreign Exchange rate Adjustments | -300.00% | -- | -100.00% | 0.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.11% | -147.03% | 1,095.24% | 57.39% | -13.86% |